Nitori Holdings Co., Ltd. (NCLTF)

Orchard Therapeutics Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Feb 20, 2022	Feb 20, 2021
Revenue	927,122	928,828	895,799	812,652	811,581	716,900
Revenue Growth (YoY)	1.87%	3.69%	10.23%	0.13%	13.21%	11.62%
Cost of Revenue	448,928	454,904	439,850	402,847	385,684	305,109
Gross Profit	478,194	473,924	455,949	409,805	425,897	411,791
Selling, General & Admin	352,728	348,576	306,145	270,649	267,220	258,080
Other Operating Expenses	-2,124	-2,711	-	-	-	-
Operating Expenses	350,604	345,865	328,223	289,739	287,627	274,104
Operating Income	127,590	128,059	127,726	120,066	138,270	137,687
Interest Expense	-3,492	-3,233	-521	-343.71	-387	-294
Interest & Investment Income	2,048	2,104	1,844	782.57	517	539
Earnings From Equity Investments	3,539	3,265	542	796.29	1,435	566
Currency Exchange Gain (Loss)	912	912	680	731.14	-77	-6
Other Non Operating Income (Expenses)	231	231	1,825	1,209	1,879	-253
EBT Excluding Unusual Items	130,828	131,338	132,096	123,241	141,637	138,239
Gain (Loss) on Sale of Investments	-	-	-	-52.29	-49	-81
Gain (Loss) on Sale of Assets	103	103	2,040	155.14	272	129
Asset Writedown	-13,994	-13,994	-10,230	-4,088	-579	-8,351
Other Unusual Items	-	-	-2	-188.57	497	760
Pretax Income	116,937	117,447	123,904	119,067	141,778	130,696
Income Tax Expense	34,987	34,899	37,381	37,528	45,054	38,582
Earnings From Continuing Operations	81,950	82,548	86,523	81,539	96,724	92,114
Minority Interest in Earnings	-3	-2	-	-	-	-
Net Income	81,947	82,546	86,523	81,539	96,724	92,114
Net Income to Common	81,947	82,546	86,523	81,539	96,724	92,114
Net Income Growth	-6.69%	-4.60%	6.11%	-15.70%	5.00%	29.02%
Shares Outstanding (Basic)	113	113	113	113	113	113
Shares Outstanding (Diluted)	113	113	113	113	113	113
Shares Change (YoY)	-	-	0.01%	0.08%	0.10%	0.17%
EPS (Basic)	725.12	730.42	765.62	721.62	856.72	817.01
EPS (Diluted)	725.12	730.42	765.62	721.62	856.72	816.66
EPS Growth	-6.69%	-4.60%	6.10%	-15.77%	4.91%	28.80%
Free Cash Flow	-	22,952	24,929	-19,316	-15,955	133,734
Free Cash Flow Per Share	-	203.09	220.59	-170.94	-141.32	1185.66
Dividend Per Share	152.000	152.000	147.000	-	140.000	123.000
Dividend Growth	3.40%	3.40%	-	-	13.82%	13.89%
Gross Margin	-	51.02%	50.90%	50.43%	52.48%	57.44%
Operating Margin	13.76%	13.79%	14.26%	14.77%	17.04%	19.21%
Profit Margin	8.84%	8.89%	9.66%	10.03%	11.92%	12.85%
Free Cash Flow Margin	-	2.47%	2.78%	-2.38%	-1.97%	18.65%
EBITDA	202,851	194,202	157,396	144,887	164,614	155,518
EBITDA Margin	-	20.91%	17.57%	17.83%	20.28%	21.69%
D&A For EBITDA	75,261	66,143	29,670	24,821	26,344	17,831
EBIT	127,590	128,059	127,726	120,066	138,270	137,687
EBIT Margin	-	13.79%	14.26%	14.77%	17.04%	19.21%
Effective Tax Rate	-	29.72%	30.17%	31.52%	31.78%	29.52%
Advertising Expenses	-	-	21,381	-	16,551	17,182

Source: S&P Global Market Intelligence. Standard template. Financial Sources.